Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oestrogens and calcium regulatory hormones: potential implications for bone

T Naveh-Many1, E Epstein, J Silver

  • 1Nephrology Services, Hadassah University Hospital, Hebrew University Hadassah Medical School, Jerusalem, Israel.

Current Opinion in Nephrology and Hypertension
|July 1, 1995
PubMed
Summary

Postmenopausal oestrogen deficiency contributes to osteoporosis. New therapies could involve estrogen analogues to boost parathyroid hormone secretion for bone health without uterine side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISUOG Consensus Statement on sonographic assessment of the endometrium: how to perform a gynecological ultrasound scan and report the findings.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Imaging in gynecological disease (28): clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023
Same author

Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Pharmacology

Background:

  • Postmenopausal oestrogen deficiency is a key factor in osteoporosis development.
  • Current oestrogen therapy halts bone loss but lacks anabolic effects.
  • Intermittent parathyroid hormone (PTH) treatment is the only known anabolic bone therapy.

Purpose of the Study:

  • To investigate the direct effect of oestrogens on parathyroid hormone (PTH) secretion.
  • To explore the potential of oestrogen analogues as a novel osteoporosis treatment.
  • To determine if oestrogens influence PTH secretion at non-uterotrophic doses.

Main Methods:

  • Assessing oestrogen's effect on PTH gene expression and secretion in parathyroid cells.
  • Evaluating PTH secretory response to calcium changes in osteoporotic patients.

Related Experiment Videos

  • Comparing oestrogen's effects at different doses to identify non-uterotrophic levels.

    • Main Results:

    • Oestrogens directly increase PTH gene expression and secretion at low, non-uterotrophic doses.
    • Osteoporotic patients exhibit a diminished PTH response to serum calcium variations.
    • This suggests a direct oestrogenic effect on the parathyroid gland.

    Conclusions:

    • Oestrogens directly stimulate PTH secretion, potentially offering an anabolic effect for osteoporosis.
    • Oestrogen analogues, at doses avoiding uterine effects, could be an optimal osteoporosis treatment.
    • Targeting parathyroid hormone secretion via selective oestrogen analogues presents a promising therapeutic strategy.